Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-31 2025-03-31 No description of principal activity false 4 2024-04-01 false 3 true The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 09301999 2024-04-01 2025-03-31 09301999 2023-04-01 2024-03-31 09301999 2025-03-31 09301999 2024-03-31 09301999 c:Director1 2024-04-01 2025-03-31 09301999 d:PlantMachinery 2024-04-01 2025-03-31 09301999 d:PlantMachinery 2025-03-31 09301999 d:PlantMachinery 2024-03-31 09301999 d:PlantMachinery d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 09301999 d:CurrentFinancialInstruments 2025-03-31 09301999 d:CurrentFinancialInstruments 2024-03-31 09301999 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 09301999 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 09301999 d:ShareCapital 2025-03-31 09301999 d:ShareCapital 2024-03-31 09301999 d:RetainedEarningsAccumulatedLosses 2025-03-31 09301999 d:RetainedEarningsAccumulatedLosses 2024-03-31 09301999 c:FRS102 2024-04-01 2025-03-31 09301999 c:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 09301999 c:FullAccounts 2024-04-01 2025-03-31 09301999 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 09301999 2 2024-04-01 2025-03-31 09301999 e:PoundSterling 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure

Registered number: 09301999 BRIAN O'ROURKE BLOODSTOCK LIMITED UNAUDITED FINANCIAL STATEMENTS INFORMATION FOR FILING WITH THE REGISTRAR FOR THE YEAR ENDED 31 MARCH 2025
BRIAN O'ROURKE BLOODSTOCK LIMITED REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF BRIAN O'ROURKE BLOODSTOCK LIMITED FOR THE YEAR ENDED 31 MARCH 2025 In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of BRIAN O'ROURKE BLOODSTOCK LIMITED for the year ended 31 March 2025 which comprise the Balance sheet and the related notes from the Company's accounting records and from information and explanations you have given us. As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at https://www.accaglobal .com/uk/en/about-us /regulation/ethics /acca-rulebook.html. This report is made solely to the director of BRIAN O'ROURKE BLOODSTOCK LIMITED in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of BRIAN O'ROURKE BLOODSTOCK LIMITED and state those matters that we have agreed to state to the director of BRIAN O'ROURKE BLOODSTOCK LIMITED in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal .com/content/dam/ACCA_Global /Technical /fact/technical-factsheet -163.pdf. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than BRIAN O'ROURKE BLOODSTOCK LIMITED and its director for our work or for this report. It is your duty to ensure that BRIAN O'ROURKE BLOODSTOCK LIMITED has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of BRIAN O'ROURKE BLOODSTOCK LIMITED. You consider that BRIAN O'ROURKE BLOODSTOCK LIMITED is exempt from the statutory audit requirement for the year. We have not been instructed to carry out an audit or review of the financial statements of BRIAN O'ROURKE BLOODSTOCK LIMITED. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements. Alder Demain & Akers Limited 2 Michaels Court Hanney Road Southmoor Oxfordshire OX13 5HR 17 December 2025 Page 1
BRIAN O'ROURKE BLOODSTOCK LIMITED REGISTERED NUMBER: 09301999 BALANCE SHEET AS AT 31 MARCH 2025
|  | 2025 |  | 2024
Note |  | £ |  | £
Fixed assets |  |  |  |  |
Tangible assets | 4 |  | 590 |  | 738
|  |  | 590 |  | 738
Current assets |  |  |  |  |
Stocks |  | 22,501 |  | 22,501 |
Debtors: amounts falling due within one year | 5 | 59,559 |  | 86,384 |
Cash at bank and in hand | 6 | 134 |  | 42,787 |
|  | 82,194 |  | 151,672 |
Creditors: amounts falling due within one year | 7 | (75,021) |  | (95,426) |
Net current assets |  |  | 7,173 |  | 56,246
Total assets less current liabilities |  |  | 7,763 |  | 56,984
Net assets |  |  | 7,763 |  | 56,984
Page 2
BRIAN O'ROURKE BLOODSTOCK LIMITED REGISTERED NUMBER: 09301999 BALANCE SHEET (CONTINUED) AS AT 31 MARCH 2025
|  | 2025 |  | 2024
Note |  | £ |  | £
Capital and reserves |  |  |  |  |
Called up share capital |  |  | 1 |  | 1
Profit and loss account |  |  | 7,762 |  | 56,983
|  |  | 7,763 |  | 56,984
The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006. The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements. The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities. The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime. The financial statements were approved and authorised for issue by the board and were signed on its behalf on 17 December 2025.
Brian O'rourke
Director
The notes on pages 4 to 8 form part of these financial statements. Page 3
BRIAN O'ROURKE BLOODSTOCK LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025
1. | General information
Brian O'Rourke Bloodstock Limited is a company limited by shares which was incorporated in England. The registered office is: 2 Michaels Court Hanney Road Southmoor Oxfordshire OX13 5HR The company's principal activity is that of pre-race horse training. 2.Accounting policies
| 2.1 | Basis of preparation of financial statements
The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view. The following principal accounting policies have been applied:
| 2.2 | Revenue
Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised: Rendering of services Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied: ∙the amount of revenue can be measured reliably; ∙it is probable that the Company will receive the consideration due under the contract; ∙the stage of completion of the contract at the end of the reporting period can be measured reliably; and ∙the costs incurred and the costs to complete the contract can be measured reliably.
| 2.3 | Operating leases: the Company as lessee
Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term. Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset. Page 4
BRIAN O'ROURKE BLOODSTOCK LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025 2.Accounting policies (continued)
| 2.4 | Interest income
Interest income is recognised in profit or loss using the effective interest method.
| 2.5 | Finance costs
Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.
| 2.6 | Pensions
Defined contribution pension plan The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations. The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds.
| 2.7 | Taxation
Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively. The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.
| 2.8 | Tangible fixed assets
Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management. Page 5
BRIAN O'ROURKE BLOODSTOCK LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025 2.Accounting policies (continued)
| 2.8 | Tangible fixed assets (continued)
Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis. Depreciation is provided on the following basis:
|  |  |  | Plant and machinery | - | 20% reducing balance
The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date. Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.
| 2.9 | Stocks
Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads. At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.
| 2.10 | Debtors
Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.
| 2.11 | Cash and cash equivalents
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.
| 2.12 | Creditors
Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
| 2.13 | Dividends
Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting. Page 6
BRIAN O'ROURKE BLOODSTOCK LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025
3. | Employees
| The average monthly number of employees, including directors, during the year was 3 (2024 - 4).
4. | Tangible fixed assets
|  | Plant and machinery
|  | £
| Cost or valuation |
| At 1 April 2024 | 5,710
| At 31 March 2025 | 5,710
| Depreciation |
| At 1 April 2024 | 4,972
| Charge for the year on owned assets | 148
| At 31 March 2025 | 5,120
| Net book value |
| At 31 March 2025 | 590
| At 31 March 2024 | 738
5. | Debtors
|  |  |  |  | 2025 | 2024
|  |  |  |  | £ | £
| Trade debtors | 50,243 | 77,068
| Other debtors | 6,277 | 6,277
| Prepayments and accrued income | 3,039 | 3,039
|  | 59,559 | 86,384
Page 7
BRIAN O'ROURKE BLOODSTOCK LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025
6. | Cash and cash equivalents
|  |  |  |  | 2025 | 2024
|  |  |  |  | £ | £
| Cash at bank and in hand | 134 | 42,787
|  | 134 | 42,787
7. | Creditors: Amounts falling due within one year
|  |  |  |  | 2025 | 2024
|  |  |  |  | £ | £
| Trade creditors | 19,377 | 23,371
| Other taxation and social security | 31,830 | 44,666
| Other creditors | 994 | 2,170
| Accruals and deferred income | 22,820 | 25,219
|  | 75,021 | 95,426
Page 8